SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001654954-18-009332
Filing Date
2018-08-17
Accepted
2018-08-17 16:42:34
Documents
1
Effectiveness Date
2018-08-17
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9335
  Complete submission text file 0001654954-18-009332.txt   10770
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-319563 | Film No.: 181026218
SIC: 2834 Pharmaceutical Preparations